Apimeds Pharmaceuticals US, Inc. (APUS)
ASE – Real Time Price. Currency in USD
1.34
-0.12 (-8.22%)
At close: May 12, 2026, 4:00 PM EDT
1.30
-0.04 (-2.99%)
After-hours: May 12, 2026, 7:55 PM EDT
Find any stock by ticker or company name

ASE – Real Time Price. Currency in USD
1.34
-0.12 (-8.22%)
At close: May 12, 2026, 4:00 PM EDT
1.30
-0.04 (-2.99%)
After-hours: May 12, 2026, 7:55 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $9.6M significantly exceed its total debt $7.8M, ensuring strong financial flexibility
Total current assets $14.0M exceed Total current liabilities $10.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (-0.8), showcasing prudent financial management
Interest coverage ratio (-32.6x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$3.8M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.31 | 2.52 | 7.0 | |
| Quick ratio | 1.31 | 1.78 | 7.0 | |
| Debt to Equity | 0.05 | -0.80 | 9.0 | |
| Debt to Assets | 0.05 | 0.73 | 9.0 | |
| Interest coverage | -32.65 | -13.90 | 1.0 | |
| Weighted average score | 6.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | -6K | -6K |
| Operating Income | -640K | -747K | -1M | -12M | -12M |
| Net Income | -669K | -778K | -1M | -6M | -6M |
| EBITDA | -640K | -747K | -1M | -12M | -12M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | 49.73 | 1.0 | |
| Operating margin % | N/A | 0.39 | 1.0 | |
| Net margin % | N/A | -50.32 | 1.0 | |
| EBITDA margin % | N/A | -16.02 | 1.0 | |
| Cash flow margin % | N/A | 124.71 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 35.14 | N/A | -119.56 | 5.5 |
| Y/Y | 999 | -270.71 | N/A | -3754.27 | 3.3 |
| 3y average | 999 | -142.24 | N/A | -393.83 | 3.3 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 3.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |